סך הכנסות החברה OraSure (OSUR)

OraSure Technologies is expanding its rollout of DNA collectors and rapid diagnostics, while the company's aggregate sales revenue on GURU.Markets reflects a period of profit stabilization following the pandemic. The 0.12 mark serves as a key metric for the current trend. High accuracy of home tests and patent protection provide OSUR with significant pricing power.

To select high-quality assets, an investor must reconcile the claimed business resilience with actual cash flow. This indicator measures the speed of fund inflows, revealing reporting anomalies or the risk of capital freeze. For OraSure Technologies (OSUR), this reflects the real demand from clinics for rapid tests and genetic devices. Revenue stability confirms the global demand for these products. By analyzing the company's trading revenue, one can assess the objective liquidity of the business.